Heparin-binding epidermal growth factor expression in KATO-III cells after Helicobacter pylori stimulation under the influence of strychnos Nux vomica and Calendula officinalis

Homeopathy

Volumn 99, Issue 3, 2010, Pages 177-182

  Hofbauer, Roland ^a   Pasching, Eva ^a   Moser, Doris ^a   Frass, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MARIGOLD EXTRACT; PLANT EXTRACT; STRYCHNOS NUX VOMICA EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; EPITHELIUM CELL; GENE EXPRESSION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; MARIGOLD; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH EPITHELIUM; STRYCHNOS NUX VOMICA;

CALENDULA; CELLS, CULTURED; GASTRIC MUCOSA; GENE EXPRESSION; HELICOBACTER PYLORI; HOMEOPATHY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PLANT EXTRACTS; RNA, MESSENGER; STRYCHNOS NUX-VOMICA;

EID: 77955235579     PISSN: 14754916     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.homp.2010.05.002     Document Type: Article

References (27)

1. Higashiyama S., Abraham J.A., Miller J., et al. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991, 251:936-939.
2. Higashiyama S., Lau K., Besner G.E., et al. Structure of heparin-binding EGF-like growth factor: multiple forms, primary structure, and glycosylation of the mature protein. J Biol Chem 1992, 267:6205-6212.
3. Lipkin M. Growth and development of gastrointestinal cells. Annu Rev Physiol 1985, 47:175-197.
4. Murayma Y., Miyagawa J.I., Higashiyama S., et al. Localisation of heparin-binding epidermal growth factor-like growth factor in human gastric mucosa. Gastroenterol 1995, 109:1051-1059.
5. Consensus Conference H. pylori infections, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention. Adv Intern Med 1996, 4:85-119.
6. Labenz J., Borsch G. Highly significant change of the clinical course of relapsing and complicated peptide ulcer disease after cure of H pylori infection. Am J Gastroenterol 1994, 89:1785-1788.
7. Wyle F., Chang K.J., Stachura J., et al. H pylori cytokines and the healing of experimental gastric ulcer. Eur J Gastroenterol Hepatol 1993, 5:75-79.
8. Romano M., Ricci V., DiPopolo A., et al. H pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells. J Clin Invest 1998, 101:1604-1613.
9. Komori M., Tsuji S., Sun W.H., et al. Gastrin enhances gastric mucosal integrity through cyclooxygenase-2 upregulation in rats. Am J Physiol Gastrointest Liver Physiol 2002, 283:1368-1378.
10. Kayanoki Y., Che W., Kawata S., et al. The effect of cilostazol, a cyclic nucleotide phosphodiesterase III inhibitor, on heparin binding EGF-like growth factor expression in macrophages and vascular smooth muscle cells. Biochem Biophys Res Commun 1997, 238:478-481.
11. Stedman T.L. Poisons & antidotes. Steadman Shorter's Medical Dictionary 1942, Wilcox & Follett Co.
12. Hänsel R., Keller K., Rimpler H., et al. Handbuch der Pharmazeutischen Praxis 1994, Vol 4. Drogen P-Z (Drugs P-Z), Springer Verlag, Berlin. 5th edn.
13. Cai B., Nagasawa T., Kadota S., et al. Processing of nux vomica. VII. Antinociceptive effects of crude alkaloids from the processed and unprocessed seeds of strychnos nux-vomica in mice. Biol Pharm Bull 1996, 19:127-131.
14. Hänsel R., Keller K., Rimpler H., et al. Hagers Handbuch der Pharmazeutischen Praxis 1992, Vol 4. Drogen A-D (Drugs A-D), Springer Verlag, Berlin.
15. Koh Y.H., Che W., Higashiyama S., et al. Osmotic stress induces HB-EGF gene expression via Ca(2+)/Pyk2/JNK signal cascades in rat aortic smooth muscle cells. J Biochem (Tokyo) 2001, 130:351-358.
16. Yoshimura K., Uchida G., Okazaki M., et al. Differential expression of heparin-binding EGF-like growth factor (HB-EGF)mRNA in normal human keratinocytes induced by a variety of natural and synthetic retinoids. Exp Dermatol 2003, 12(Suppl. 2):28-34.
17. Naglich J.G., Metherall J.E., Russell D.W., et al. Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell 1992, 69:1051-1061.
18. Iwamoto R., Mekada E. Heparin-binding EGF-like growth factor: a juxtacrine growth factor. Cytokine Growth Factor Rev 2000, 11:335-344.
19. Miyazaki Y., Shinomura S., Higashiyama S., et al. Heparin-binding EGF like growth factor is an autocrine growth factor for rat gastric epithelial cells. Biochem Biophys Res Commun 1996, 223:36-41.
20. Barnard J.A., Beauchamp R.D., Russell W.E., et al. Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology 1995, 108:564-580.
21. Resch G., Gutmann V. Scientific Foundations of Homoeopathy 1987, O. Verlag, Berg Starnberger See.
22. Ran J., Zhao L., Xu Q., et al. Solubilization of cyclosporin A. AAPS Pharm Sci Tech 2001, 18:E2.
23. Ahmed M.O. Comparison of impact of the different hydrophilic carriers on the properties of piperazine-containing drug. Eur J Pharm Biopharm 2001, 51:221-225.
24. Sukul A., Sinhabau S.P., Sukul N.C. Reduction of alcohol induced sleep time in albino mice by potentized Nux vomica prepared with 90% ethanol. Br Homeopath J 1999, 88:58-61.
25. Gupta R., Manchanda R.K. Reiter's disease treated with Nux vomica. Homeopathy 2006, 95:103-104.
26. Deng X.K., Yin W., Li W.D., et al. The anti-tumor effects of alkaloids from the seeds of Strychnos nux-vomica on HepG2 cells and its possible mechanism. J Ethnopharmacol 2006, 106:179-186.
27. Sukul N.C., Ghosh S., Sinhababu S.P., et al. Strychnos nux-vomica extract and its ultra-high dilution reduce voluntary ethanol intake in rats. J Altern Complement Med 2001, 7:187-193.